List of Veregen drug patents

Veregen is owned by Ani Pharms.

Veregen contains Sinecatechins.

Veregen has a total of 3 drug patents out of which 1 drug patent has expired.

Expired drug patents of Veregen are:

  • US10434059

Veregen was authorised for market use on 31 October, 2006.

Veregen is available in ointment;topical dosage forms.

Veregen can be used as treatment of genital warts.

The generics of Veregen are possible to be released after 02 October, 2026.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10434059 ANI PHARMS Medicament for the treatment of viral skin and tumour diseases
Nov, 2022

(2 months ago)

US9770406 ANI PHARMS Medicament for the treatment of viral skin and tumour diseases
Jul, 2025

(2 years from now)

US7858662 ANI PHARMS Medicament for the treatment of viral skin and tumour diseases
Oct, 2026

(3 years from now)

Drugs and Companies using SINECATECHINS ingredient

Market Authorisation Date: 31 October, 2006

Treatment: Treatment of genital warts

Dosage: OINTMENT;TOPICAL

More Information on Dosage

VEREGEN family patents

5

United States

4

European Union

3

Germany

2

Hong Kong

2

Spain

1

Austria

1

Korea, Republic of

1

Brazil

1

Australia

1

Israel

1

Cyprus

1

Mexico

1

Japan

1

Argentina

1

South Africa

1

Portugal

1

Belgium

1

Russia

1

China

1

Canada

1

Denmark

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in